CA Patent

CA3158951A1 — 4-substituted aminoisoquinoline derivatives

Assigned to Purdue Research Foundation · Expires 2018-02-22 · 8y expired

What this patent protects

This invention relates to 4-substituted isoquinoline compounds and their derivatives and uses thereof for treatment of cancer, for example, acute myeloid leukemia.

USPTO Abstract

This invention relates to 4-substituted isoquinoline compounds and their derivatives and uses thereof for treatment of cancer, for example, acute myeloid leukemia.

Drugs covered by this patent

Patent Metadata

Patent number: CA3158951A1
Jurisdiction: CA
Classification: —
Expires: 2018-02-22
Drug substance claim: No
Drug product claim: No
Assignee: Purdue Research Foundation
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.